Janky R, Varga V, Saransaari P, Oja SS
M., Muhammad, N., Lieu, E
Unmanageable hunger during tapering suggests your body may benefit from longer-term GLP-1 therapy or a maintenance microdose rather than full discontinuation
The retrospective cohort study, GLP-1 Receptor Agonist Use and Weight Change in Patients With Breast Cancer, published in the August 2025 edition of Oncology , 3 was based on data from 116 patients with a breast cancer diagnosis prescribed GLP-1 RAs at the Memorial Sloan Kettering Cancer Center, from 2015 to 2023
Factors impacting the survival of children with intestinal failure referred for intestinal transplantation
Brain Pathol